Fortfahren mit
Größe auswählen
| Größe/SKU | Verfügbarkeit | Preis |
|---|---|---|
0.2 mL | Warenkorb auf Verfügbarkeit prüfen | € 512,00 |
Über diesen Artikel
biological source
mouse
Quality Segment
conjugate
unconjugated
antibody form
ascites fluid
antibody product type
primary antibodies
clone
GAL-40, monoclonal
contains
15 mM sodium azide
species reactivity
bacteria
technique(s)
dot blot: suitable using soluble β-galactosidase, immunocytochemistry: suitable, western blot: 1:1,000 using denatured-reduced Escherichia coli β-galactosidase
isotype
IgM
shipped in
dry ice
storage temp.
−20°C
target post-translational modification
unmodified
General description
Immunogen
Application
Biochem/physiol Actions
Disclaimer
1 of 1
Dieser Artikel | |||
|---|---|---|---|
| description clone GAL-40, ascites fluid | description clone GAL-13, ascites fluid | description purified immunoglobulin, buffered aqueous solution | description liquid, Calbiochem® |
| species reactivity bacteria | species reactivity bacteria | species reactivity - | species reactivity mouse |
| antibody form ascites fluid | antibody form ascites fluid | antibody form purified immunoglobulin | antibody form affinity isolated antibody |
| clone GAL-40, monoclonal | clone GAL-13, monoclonal | clone T7 Tag | clone polyclonal |
| conjugate unconjugated | conjugate unconjugated | conjugate - | conjugate - |
| biological source mouse | biological source mouse | biological source mouse | biological source goat |
| shipped in dry ice | shipped in dry ice | shipped in dry ice | shipped in wet ice |
Still not finding the right product?
Explore all of our products under Monoclonal Anti-β-Galactosidase antibody produced in mouse
— oder —
Probieren Sie unser Produkt-Auswahlhilfe, um Ihre Auswahl einzugrenzen
Lagerklasse
10 - Combustible liquids
WGK
nwg
Flammpunkt (°F)
Not applicable
Flammpunkt (°C)
Not applicable
Hier finden Sie alle aktuellen Versionen:
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.



